Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Brain : a Journal of Neurology
|
June 5, 2014
Targeting impulsivity in Parkinson's disease using atomoxetine
Angie A Kehagia, Charlotte R Housden, Ralf Regenthal, et al.
Journal of Psychiatry & Neuroscience : JPN
|
April 27, 2021
A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss
Carolin A Lewis, Karsten Mueller, Rachel G Zsido, et al.
Plos One
|
April 21, 2022
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers
Michael Rode, Kolja Nenoff, Kerstin Wirkner, et al.
Brain Sciences
|
November 11, 2022
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
Christian Schinke, Michael Rullmann, Julia Luthardt, et al.
Frontiers in Neuroscience
|
September 26, 2022
The attention-emotion interaction in healthy female participants on oral contraceptives during 1-week escitalopram intake
Nathalie Beinhölzl, Eóin N Molloy, Rachel G Zsido, et al.
Human Brain Mapping
|
January 22, 2022
One-week escitalopram intake alters the excitation-inhibition balance in the healthy female brain
Rachel G Zsido, Eóin N Molloy, Elena Cesnaite, et al.
Neuroscience
|
March 9, 2026
BDNF Val66Met polymorphism is linked to elevated levels of serotonin-transporter in the medial prefrontal cortex but not to altered eating behavior
Anke McLeod, Michael Rullmann, Philipp Hinderberger, et al.
Free Radical Biology & Medicine
|
March 8, 2006
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity
Susana Garcia de Arriba, Ute Krügel, Ralf Regenthal, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 11, 2021
Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder
Peter Zhukovsky, Sharon Morein-Zamir, Hisham Ziauddeen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2014
Altered serotonin transporter availability in patients with multiple sclerosis
Swen Hesse, Franziska Moeller, David Petroff, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Brain : a Journal of Neurology
|
June 5, 2014
Targeting impulsivity in Parkinson's disease using atomoxetine
Angie A Kehagia, Charlotte R Housden, Ralf Regenthal, et al.
Journal of Psychiatry & Neuroscience : JPN
|
April 27, 2021
A single dose of escitalopram blunts the neural response in the thalamus and caudate during monetary loss
Carolin A Lewis, Karsten Mueller, Rachel G Zsido, et al.
Plos One
|
April 21, 2022
Impact of medication on blood transcriptome reveals off-target regulations of beta-blockers
Michael Rode, Kolja Nenoff, Kerstin Wirkner, et al.
Brain Sciences
|
November 11, 2022
HPA Axis Responsiveness Associates with Central Serotonin Transporter Availability in Human Obesity and Non-Obesity Controls
Christian Schinke, Michael Rullmann, Julia Luthardt, et al.
Frontiers in Neuroscience
|
September 26, 2022
The attention-emotion interaction in healthy female participants on oral contraceptives during 1-week escitalopram intake
Nathalie Beinhölzl, Eóin N Molloy, Rachel G Zsido, et al.
Human Brain Mapping
|
January 22, 2022
One-week escitalopram intake alters the excitation-inhibition balance in the healthy female brain
Rachel G Zsido, Eóin N Molloy, Elena Cesnaite, et al.
Neuroscience
|
March 9, 2026
BDNF Val66Met polymorphism is linked to elevated levels of serotonin-transporter in the medial prefrontal cortex but not to altered eating behavior
Anke McLeod, Michael Rullmann, Philipp Hinderberger, et al.
Free Radical Biology & Medicine
|
March 8, 2006
Carbonyl stress and NMDA receptor activation contribute to methylglyoxal neurotoxicity
Susana Garcia de Arriba, Ute Krügel, Ralf Regenthal, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
September 11, 2021
Prefrontal Cortex Activation and Stopping Performance Underlie the Beneficial Effects of Atomoxetine on Response Inhibition in Healthy Volunteers and Those With Cocaine Use Disorder
Peter Zhukovsky, Sharon Morein-Zamir, Hisham Ziauddeen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 25, 2014
Altered serotonin transporter availability in patients with multiple sclerosis
Swen Hesse, Franziska Moeller, David Petroff, et al.
Page
of 6